Back to Biogen

Biogen News

BIIB

Biogen Q2 & Q3 2026 R&D Expense Guidance

Biogen (BIIB) issues preliminary R&D expense and EPS impact estimates for Q2 and Q3 2026; analysis of pipeline funding, milestones and investor implications.

1 July 2026BIOGEN INC.
All news